Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,437.20
-21.80 (-0.89%)
Sep 4, 2026, 3:14 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 687.78 billion as of September 4, 2026. Its market cap has increased by 21.59% in one year.
Market Cap
687.78B
Enterprise Value
681.95B
Revenue
177.37B
Ranking
n/a
PE Ratio
38.27
Stock Price
2,437.20
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 687.78B, an increase of 59,743.20%. That is a compound annual growth rate of 28.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 687.78B | 19.75% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.14T |
| Cipla | 1.13T |
| Laurus Labs | 1.01T |
| Mankind Pharma | 987.68B |
| Aurobindo Pharma | 948.34B |
| Alkem Laboratories | 622.93B |
| Ipca Laboratories | 496.27B |
| Gland Pharma | 479.71B |